Page last updated: 2024-11-07

carbachol and Hyphema

carbachol has been researched along with Hyphema in 1 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Hyphema: Bleeding in the anterior chamber of the eye.

Research Excerpts

ExcerptRelevanceReference
"A 78-year-old woman with bilateral exfoliation glaucoma who was receiving warfarin, 2 mg daily, for systemic anticoagulation developed acute visual loss in the right eye several hours after pupillary dilation."7.70Hyphema associated with pupillary dilation in a patient with exfoliation glaucoma and warfarin therapy. ( Greenfield, DS; Liebmann, JM; Ritch, R, 1999)
"A 78-year-old woman with bilateral exfoliation glaucoma who was receiving warfarin, 2 mg daily, for systemic anticoagulation developed acute visual loss in the right eye several hours after pupillary dilation."3.70Hyphema associated with pupillary dilation in a patient with exfoliation glaucoma and warfarin therapy. ( Greenfield, DS; Liebmann, JM; Ritch, R, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenfield, DS1
Liebmann, JM1
Ritch, R1

Other Studies

1 other study available for carbachol and Hyphema

ArticleYear
Hyphema associated with pupillary dilation in a patient with exfoliation glaucoma and warfarin therapy.
    American journal of ophthalmology, 1999, Volume: 128, Issue:1

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Carbachol; Cerebrovascular Disorders; Drug Therapy, Combi

1999